CDSCO Public Notices on Medical Devices Explained

Public Notices Published by CDSCO and Their Impact on Medical Devices

Over the past year, the Central Drugs Standard Control Organization (CDSCO) has issued several public notices and clarifications shaping the regulatory environment for medical devices in India. These updates reflect the government's focus on compliance, transparency, patient safety, and industry facilitation. Below is a consolidated analysis of major notices, their meaning, and potential impact on the medical device ecosystem.

The table below shows the list of public notices released in the last year period:

Sr. No.	Date	Title	Impact
1.	Sep 17, 2025	Release of ICMR-CDSCO Standard Performance Evaluation Protocols	The protocols establish uniform performance evaluation standards for IVD kits, ensuring consistent quality across laboratories in India and enabling independent verification of manufacturers' claims on sensitivity, specificity, and reliability, strengthening diagnostic confidence. These protocols improve patient safety, regulatory clarity, and industry competitiveness in the diagnostics sector.
2.	Sep 15, 2025	Separate provision for subsequent importers in the online system.	The CDSCO's new "Subsequent Importer" provision streamlines the process for importing already approved medical devices and IVDs. It reduces documentation and processing timelines by separating brand approval from routine endorsements. This step enhances regulatory clarity, transparency, and faster market access for multiple importers.
3.	Sep 11, 2025	Stickering on medical products due to the GST rate reduction.	While this looks like a minor administrative update, it directly affects manufacturers and distributors, who must ensure timely compliance to avoid penalties and stock issues. Patients may benefit from reduced GST prices.
4.	Aug 26, 2025 / Aug 12, 2025 / Jan 29, 2025 / Jan 02, 2025	Invitation for comments on draft IVD evaluation protocol.	The CDSCO-ICMR protocol standardizes evaluation methods for IVD kits detecting pulmonary and drug-resistant tuberculosis. It ensures the availability of quality-assured diagnostic tools tailored for Indian needs. This strengthens diagnostic accuracy, patient safety, and global acceptance of India-made TB IVDs.
5.	Jun 24, 2025	Regulatory requirements for outsourcing sterilization activity.	With sterilization being a critical quality step, this notice clarifies accountability when outsourced. It signals CDSCO's intent to enforce quality control across the entire supply chain, not just at manufacturing sites.
6.	Jun 04, 2025	Updated list of laboratories for IVD performance evaluation.	The updated list of laboratories expands the network for IVD performance evaluation, ensuring wider access to accredited testing centers. It enhances regulatory efficiency and reliability by standardizing evaluations across recognized facilities.
7.	Apr 09, 2025	Provision for system auto-generated Neutral Code by the manufacturer for export purposes under the Medical Devices Rules 2017	The CDSCO has enabled a system-generated Neutral Code for medical device exports, replacing manual issuance by the Central Licensing Authority. Manufacturers can now obtain the code directly via the Online System of Medical Devices portal, simplifying regulatory procedures.
8.	Apr 09, 2025	Provision for auto-generated Market Standing Certificate and Non-Conviction Certificate for licensed medical devices	CDSCO has introduced an auto-generated workflow for Market Standing Certificates (MSC) and Non-Conviction Certificates (NCC) for licensed medical devices, streamlining the application process. All existing applications under the old system will be rejected, requiring stakeholders to re-submit via the upgraded online portal.
9.	Mar 04, 2025	Launch of Clinical Research Organisation (CRO) registration via SUGAM.	Moving key applications and certifications onto the SUGAM portal reduces paperwork, brings speed and transparency, and aligns with the government's "Digital India" push. It also minimizes human errors and enhances audit trails.
10.	Feb 24, 2025	Online submission for site addition/change of Principal Investigator (PI).	The submissions of clinical trials and PI are available on the Sugam Portal and can be done online now.
11.	Feb 17, 2025	Stakeholder comments invited on the IVD adverse event reporting form.	A stronger framework for adverse event reporting improves patient safety and aligns India with international pharmacovigilance and device-vigilance practices. Draft Good Clinical Practice guidelines underline India's seriousness in clinical research governance.
12.	Jan 06, 2025	Draft update to the risk-based classification list.	Streamlining risk classification reduces ambiguity for manufacturers and investors. It helps ensure that regulatory controls are proportionate to the device's risk level, preventing over- or under-regulation.
13.	Jan 01, 2025	Merging of existing risk classification lists.	CDSCO has merged existing medical device risk classification lists to create a unified framework. This simplifies regulatory reference and ensures consistent risk categorization for all devices.

Conclusion

Nearly 47% of the notices (7 out of 15) are focused on either performance evaluation or digitalization, showing CDSCO's dual priority of strengthening quality standards and modernizing regulatory workflows.